Enzo Biochem, Inc. operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enzo Biochem with three other
pharmaceutical manufacturers in North America:
Enanta Pharmaceuticals Inc
sales of $88.27 million
Array BioPharma Inc.
of which 100%
was Small Molecular Drugs), and
Natural Alternatives International, Inc.
of which 81%
was Private Label Contract Manufacturing).
During the year ended July of 2016, sales at
Enzo Biochem were $102.77 million.
increase of 5.3%
versus 2015, when the company's sales were $97.60 million.
This was the third consecutive year of growth at Enzo Biochem.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Enzo Biochem had sales
of $102.03 million.
Sales of Clinical Labs saw an increase
that was more than double the company's growth rate: sales were up
11.8% in 2016, from
$63.41 million to $70.92 million.
Not all segments of Enzo Biochem experienced an increase in sales in 2016:
sales of Life Sciences fell 6.8% to $31.86 million.